Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-29 | He is a Partner of ValueAct Capital Management, LP, a governance-oriented investment fund which invests in a concentrated portfolio of public companies. |
| 2017-03-23 | Mr. Hale has worked on investments in the pharmaceutical, medical device, information technology and business services industries. |
| 2018-03-21 | Mr. Hale is a Partner of ValueAct Capital Management, L.P., a governance-oriented investment fund which invests in a concentrated portfolio of public companies and works collaboratively with management and the board of directors on matters such as strategy, capital structure, M&A and talent management. |
| 2019-03-18 | Mr. Hale has worked on investments in the pharmaceutical, medical device, information technology and business services industries. Prior to joining ValueAct Capital in January 2011, Mr. Hale was a Principal with The Parthenon Group, a strategy consultancy firm. |
| 2020-03-16 | Mr. Hale has worked on investments in the pharmaceutical, medical device, information technology and business services industries. Prior to joining ValueAct Capital in January 2011, Mr. Hale was a Principal with The Parthenon Group, a strategy consultancy firm. |
| 2021-03-18 | Mr. Hale has an A.B. from Dartmouth College. He has worked in investment and strategy consulting roles, including at ValueAct Capital and The Parthenon Group. |
Data sourced from SEC filings. Last updated: 2025-10-11